InVitria

InVitria enhances cell culture, bioproduction, and final product formulation with innovative, sustainable solutions. As a leading manufacturer of recombinant proteins and cell culture supplements, the company supports the development of vaccines, biologics, cell and gene therapies, and regenerative medicine products.

With its proprietary ExpressTec system, InVitria eliminates animal-derived components by leveraging plant-based production systems. This ensures safe, effective, and sustainable alternatives to serum and serum proteins, making it an ideal choice for companies in biopharmaceutical manufacturing.

Optimize your cell culture processes – Contact us for tailored solutions in cell and gene therapy, vaccine development, and bioproduction.